Abstract
Newly developed alpha1-adrenoceptor antagonists including naftopidil are free from the "prazosin-like" side effect of orthostatic hypotension and associated symptoms. We investigated the mechanism for the differential effects of naftopidil and prazosin on the development of postural hypotension, with special attention on their selectivity for the alpha1-adrenoceptor subtype. We observed that head-up tilt caused a similar extent of drop in mean arterial pressure in control, naftopidil (1 mg/kg)- or prazosin (10 microg/kg)-treated rats; however, the tilt-induced postural hypotension was recovered within 2 min in the naftopidil-treated group, but not in the prazosin-treated group. Comparing an inhibitory effect on noradrenaline-induced contraction in the rat aorta and portal vein, we found that naftopidil was sixfold less potent in the portal vein, while prazosin showed similar potency in both tissues. Reverse transcription-polymerase chain reaction analysis showed that the expression of alpha1d-adrenoceptor mRNA predominated in the aorta, while that of alpha1b-adrenoceptor mRNA predominated in the portal vein. Using cloned rat alpha1-adrenoceptor subtypes, we found that naftopidil was selective for the alpha1d-subtype with approx...Continue Reading
References
Dec 1, 1992·Journal of Cardiovascular Pharmacology·G SponerB Jakob
Jul 17, 1991·JAMA : the Journal of the American Medical Association·A F Khoury, N M Kaplan
Mar 1, 1991·Japanese Journal of Pharmacology·I MuramatsuS Kigoshi
Oct 1, 1990·The Journal of Urology·K KawabeH Kato
Feb 25, 1990·Nucleic Acids Research·M M VoigtH M Chin
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S CotecchiaB K Kobilka
Mar 11, 1985·Nucleic Acids Research·P FortJ M Blanchard
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Jan 1, 1982·Journal of Pharmacological Methods·S J Humphrey, R B McCall
Jan 16, 1995·European Journal of Pharmacology·R FoglarG Tsujimoto
Jul 1, 1995·British Journal of Pharmacology·B A KennyA M Naylor
Jan 1, 1995·Life Sciences·R TestaA Leonardi
Apr 24, 1995·FEBS Letters·A HirasawaG Tsujimoto
Aug 16, 1994·European Journal of Pharmacology·K HorieG Tsujimoto
Jul 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S G Carruthers
May 1, 1994·Postgraduate Medical Journal·M J FarthingP Turner
Sep 15, 1993·Biochemical and Biophysical Research Communications·A HirasawaG Tsujimoto
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Citations
Apr 25, 2009·European Journal of Pharmacology·Shinya KobayashiYoshinobu Yamazaki
Jun 11, 1999·Japanese Journal of Pharmacology·R TakeiT Asano
Nov 17, 2009·The Journal of Urology·Shinya KobayashiKenjiro Kohri
Jul 19, 2017·Pflügers Archiv : European journal of physiology·Toshio Kitazawa, Kazuyo Kitazawa
Oct 21, 2000·Hypertension·R E ShapiroD E Berkowitz
Jun 11, 2008·Psychopharmacology·Z NourianM J Mulvany
Mar 7, 2006·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yoshitaka TomiyamaNobuo Shibata
Aug 2, 2011·Cardiovascular Toxicology·Sandra PicardRené Rouet
Dec 12, 2012·Asian Journal of Andrology·Hui DingZhi-Ping Wang
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Arthur A HancockMichael Williams
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·David G WitteArthur A Hancock
Nov 7, 2002·Japanese Journal of Pharmacology·Katsuyoshi AkiyamaMakio Kitazawa
Jul 31, 2020·International Journal of Molecular Sciences·Romane FlorentMonique N'Diaye
Mar 1, 2008·Current Protocols in Pharmacology·Philippe GuillaumePierre Lacroix
Jul 3, 2016·Acta Physiologica·R MatosA Charrua